Patent Assignment
Reel/Frame 057679/0342
Corrective Assignment to Correct the Application Number 63057975 Previously Recorded on Reel 057528 Frame 0064. Assignor(S) Hereby Confirms the Change of Name.
Recorded: 2021-09-30
Pages: 5
Assignor
IMMUNITYBIO, INC.
Executed: 2021-03-09
Assignee
NANTCELL, INC.
9920 JEFFERSON BLVD., CULVER CITY, CALIFORNIA, 90232
Covered Property
(1)
Anti COVID-19 Therapies Targeting Nucleocapsid & Spike Proteins
Application:
63/059,975 →
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.